Pregnancy in Diabetes | Dexcom Provider

the only CGM* with proven accuracy and safety in pregnancy¹

DEXCOM G7 WAS SHOWN TO BE ACCURATE AND SAFE IN PATIENTS WITH TYPE 1, TYPE 2, AND GESTATIONAL DIABETES¹

missed readings can lead to undetected hypo- and hyperglycemic events during pregnancy^1-5

up to 98.3% of daily readings can be missed with conventional BGM and fingersticks^†

Real-time CGM like Dexcom G7 delivers positive outcomes and
may help reduce risks^‡,1,4,6-9

For your pregnant patients, real-time CGM can lower:

risk of hyperglycemia^§,1,10

risk of preeclampsia^||,1,11

gestational weight gain^||,1,12

rate of C-sections^||,1,11

A1C^1,10,13,14

And for their baby, real-time CGM may decrease instances of:

LGA^§,15

neonatal hypoglycemia^§,15

NICU admissions^§,15

diabetes can add a mental burden to pregnant patients¹⁶— continuous glucose monitoring may help

dexcom warrior

outcomes from a study with 350 pregnant patients with diabetes showed¹⁶:

fear of hypoglycemia was a predictor of depression and anxiety¹⁶

depression and anxiety can lead to increased insulin resistance and poor glucose control¹⁶

reducing the fear of hypoglycemia may improve the mental health of pregnant patients with diabetes¹⁶

simplifying disease management for your patients

no fingersticks^¶ required

easy, painless application of the sensor to the back of the arm¹⁷

better treatment decisions for preventing hypo- and hyperglycemic events^1,2

using the Share/Follow feature helps reduce fear of hypoglycemia¹⁸

patients can pick up their sensor at their local pharmacy

simple to replace the sensor at home every 10 days¹⁷

listen to Real-Time Real Talk for a breakdown on navigating

pregnancy with diabetes

get your patients

started for free today

PRESCRIBE & SAMPLE

more patients pay $0 for

Dexcom G7 compared to Libre^#,19

COVERAGE & AFFORDABILITY

BGM = blood glucose monitoring; CGM = continuous glucose monitoring; LGA = large for gestational age; NICU = neonatal intensive care unit.

*Based on commercially available CGM systems. †Based on a person testing blood glucose 5x a day vs. 288 readings using Dexcom CGM. ‡Studies have demonstrated an association between elevated glucose and increased incidence of cesarean delivery, preeclampsia, and birth weight >90th percentile. §Study conducted in pregnant women with T1D. ||Study conducted in pregnant women with gestational diabetes. ¶Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. #Individual pricing may vary depending on commercial insurance coverage.

1 Polsky S, et al. Diabetes Technol Ther. 2024;26(5):307-312. 2 Sola-Gazagnes A, et al. Diabetes Metab. 2020;46(2):158-163. 3 American Diabetes Association. Standards of Care in Diabetes. Diabetes Care. 2023;46:S1-S291. 4 The American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;131(2):e49-e64. 5 Chen R, et al. J Matern Fetal Neonatal Med. 2003;14(4):256-260. 6 Hapo Study Cooperative Research Group, et al. N Engl J Med. 2008;358(19):1991-2002. 7 Beck RW, et al. JAMA. 2017;317(4):371-378. 8 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 9 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 10 Feig DS, et al. Lancet. 2017;390(10110):2347-2359. 11 Yu F, et al. J Clin Endocrinol Metab. 2014;99(12):4674-4682. 12 Wei Q, et al. Sci Rep. 2016;6:19920. 13 Murphy HR, et al. BMJ. 2008;337:a1680. 14 García-Moreno RM, et al. Diabet Med. 2022;39:e14703. 15 Murphy HR. Diabetologia. 2019;62(7):1123-1128. 16 Salimi HR, et al. Diabet Epidemiol Manag. 2024;14:1-7. 17 Dexcom G7 User Guide, 2023. 18 Polsky S, et al. J Diabetes Sci Technol. 2020;14(1):191-192. 19 Dexcom, Data on File, 2024.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.